Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Regado Biosciences

Request full access

Develops antithrombotic drug systems for acute and sub-acute cardiovascular and other indications

Durham, United StatesFounded 2001Biotech & Life Sciences

About Regado Biosciences

Regado Biosciences is at the forefront of developing innovative therapeutic technologies, focusing on creating two-component drug systems. These systems consist of a nuclease-stabilized RNA aptamer and a complementary oligonucleotide active control agent, allowing for precise control over therapeutic effects. The company's primary application is in the field of injectable antithrombotics, including anticoagulants and antiplatelet agents, targeting the acute and sub-acute care market. This market is substantial, valued in the billions, and demands safer and more controllable therapeutic options. Regado's technology aims to provide physicians with the ability to actively manage and personalize treatment, enhancing patient safety and outcomes. The business model revolves around the development and commercialization of these advanced therapeutic systems, generating revenue through partnerships, licensing agreements, and direct sales to healthcare providers.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2001
Headquarters
Durham, United States
Listing
IPO 2013
Employees
2
Open positions
None listed
Dealroom signal
58.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B, B2C
Links
Website

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITYOther financing Jan 2014 $20M — Undisclosed —
IPOOther financing Aug 2013 $0 — Undisclosed —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

Regado Biosciences website traffic

Latest recorded traffic for Regado Biosciences is 0 monthly website visits. Regado Biosciences's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Regado Biosciences in the Durham ecosystem

Live from Dealroom

The Regado Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later7 investors entered at this stage

  • Caxton Advantage Life Sciences Fund
  • Domain Associates
  • Andera Partners
  • RMI Partners
  • Quaker Partners
  • Baxter Ventures
  • Rusnano

Other known investors1 additional known investor

  • Duke University
Team profiled 18 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Durham HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Regado Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Regado Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.